2016-05-24 23:04:36 UTC

Dr. Isaacs Receives AGA 2016 Distinguished Clinician Award

May 22, 2016

Kim L. Isaacs, MD, PhD, AGAF, received the award during DDW® 2016.

AGA is honored to present the Distinguished Clinician Award, Clinical Academic Practice, to Kim L. Isaacs, MD, PhD, AGAF. Dr. Isaacs is considered the consummate physician by her peers in the field and by her patients, who come from all over for her specific expertise and care. As a leader in the inflammatory bowel disease community, she combines her technical skills and tremendous breadth of knowledge with extreme empathy and compassion for her patients. Dr. Isaacs exemplifies what being a doctor in this modern age is really about, using her vast experience of taking care of IBD patients for the past 25 years and propelling the community forward through new clinical trials and promoting a multidisciplinary approach to helping patients manage their illnesses. 

Dr. Isaacs is the co-director of the University of North Carolina (UNC), Chapel Hill, Multidisciplinary Inflammatory Bowel Diseases Center and serves as the associate program director for the GI fellowship program at UNC. She helped establish a multidisciplinary IBD clinic at UNC, which exemplifies a true patient-centric center. She also started a branch of the center devoted to randomized controlled trials for the purpose of allowing patients with refractory disease access to novel therapies. 

As a full-time clinician, Dr. Isaacs has the scientific knowledge to approach clinical trials with a much deeper understanding of disease mechanisms than most clinical trial researchers. She has over 50 peer-reviewed publications, numerous book chapters, and a well-received textbook on pregnancy and GI disorders that received a five-star review from Gastroenterology. All of her academic accomplishments have not taken her from her top priority of serving her patients. Press-Ganey feedback scores from UNC show that she is adored by patients, who give her a perfect score and emphasize that UNC is lucky to have her. She is called “super-woman” by her patients and colleagues alike. 

In addition to these amazing contributions to the field, she remains a dedicated member of AGA, having served on the Education and Training Committee, including as chair of the CME Subcommittee, Nominating Committee of the Clinical Practice section of the AGA Council, and Constitution and Bylaws Committee, and was elected to the AGA Academy of Educators. She has also participated in the AGA mentoring program for trainees for a number of years. Dr. Isaacs is a member of the Crohn’s and Colitis Foundation of America, the Sigma Xi Scientific Research Society, the Women Educators and Clinicians, Researchers in IBD (member and officer), ACG and ASGE. 

Her gifts as an educator, communicator and overall well-loved physician have all been honored in the numerous awards she has collected over the years. She was named the 2015 UNC Health Care and Faculty Physicians Carolina Care Excellence Leader, as well as the UNC Gastroenterology Fellow Teaching Award, the UNC GI Fellows Program Mentoring Award, the Crohn’s and Colitis Foundation Premier Physician Award, and has been on the Best Doctors in America list for well over a decade. 

Dr. Isaacs received her PhD in pathology and her medical degree from the State University of New York at Stony Brook. She completed her residency and chief residency at the University of North Carolina, Chapel Hill, where she also continued as a GI fellow. Later, Dr. Isaacs was asked to join the UNC faculty and help anchor the clinical program in IBD patient care, where she remains today.

More on IBD

2018 AGA Postgraduate Course

June 2, 2018

Secure your spot for this clinically focused, multi-topic course that offers immediately applicable information. Held in conjunction with DDW®. Save $75 when you register by April 18.

Advancing Collaborative Approaches in IBD Treatment Decision-Making

March 14, 2018

This is a unique opportunity for payers and providers to gather in the same room to discuss IBD therapy selection, disease monitoring, treatment criteria and access.

Advancing Collaborative Approaches in IBD Treatment Decision-Making

March 12, 2018

This is a unique opportunity for payers and providers to gather in the same room to discuss IBD therapy selection, disease monitoring, treatment criteria and access.